KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks
NASDAQ:ALXN
Delisted

Alexion Pharmaceuticals Stock Price (Quote)

$182.50
+0 (+0%)
At Close: May 27, 2022

Range Low Price High Price Comment
30 days $182.50 $182.50 Friday, 27th May 2022 ALXN stock ended at $182.50. During the day the stock fluctuated 0% from a day low at $182.50 to a day high of $182.50.
90 days $182.50 $182.50
52 weeks $174.72 $187.45

Historical Alexion Pharmaceuticals prices

Date Open High Low Close Volume
Apr 27, 2021 $167.55 $168.18 $166.95 $167.06 1 896 158
Apr 26, 2021 $166.80 $167.43 $166.23 $167.00 2 229 387
Apr 23, 2021 $167.30 $167.77 $166.57 $166.92 1 597 319
Apr 22, 2021 $167.83 $168.48 $167.02 $167.65 2 194 379
Apr 21, 2021 $167.72 $168.52 $167.39 $168.44 1 829 515
Apr 20, 2021 $165.94 $166.81 $165.58 $166.54 3 386 629
Apr 19, 2021 $164.51 $165.95 $164.51 $165.47 3 684 831
Apr 16, 2021 $164.05 $164.60 $163.54 $163.68 7 289 619
Apr 15, 2021 $156.61 $158.36 $156.20 $157.54 1 801 507
Apr 14, 2021 $154.34 $156.32 $154.34 $155.29 2 041 759
Apr 13, 2021 $153.85 $154.51 $153.01 $153.73 1 084 457
Apr 12, 2021 $154.69 $155.00 $153.94 $154.01 2 404 880
Apr 09, 2021 $154.89 $155.53 $154.55 $155.01 1 112 403
Apr 08, 2021 $154.25 $155.29 $153.71 $154.47 1 240 281
Apr 07, 2021 $153.69 $153.69 $151.75 $152.35 1 651 366
Apr 06, 2021 $153.54 $154.79 $153.21 $153.41 1 716 479
Apr 05, 2021 $153.40 $154.29 $152.95 $154.12 1 332 904
Apr 01, 2021 $152.81 $153.73 $152.41 $153.21 2 060 655
Mar 31, 2021 $153.60 $154.39 $152.77 $152.91 1 802 561
Mar 30, 2021 $154.86 $154.86 $153.17 $153.45 1 558 422
Mar 29, 2021 $154.03 $155.96 $154.03 $155.57 2 021 321
Mar 26, 2021 $151.80 $154.92 $151.80 $154.88 1 469 437
Mar 25, 2021 $151.97 $153.45 $151.75 $152.97 2 262 741
Mar 24, 2021 $152.03 $152.32 $151.14 $151.54 2 232 052
Mar 23, 2021 $152.39 $153.36 $151.25 $152.18 2 483 520
Click to get the best stock tips daily for free!

About Alexion Pharmaceuticals

Alexion Pharmaceuticals Alexion Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes life-transforming therapeutic products. The company offers Soliris (eculizumab), a monoclonal antibody for the treatment of paroxysmal nocturnal hemoglobinuria (PNH), a genetic blood disorder; and atypical hemolytic uremic syndrome (aHUS), a genetic disease. It provides Strensiq (asfotase alfa), a targeted enzyme replacement therapy for patients with hypophosp... ALXN Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT